" Kaohsiung Medical University Chung-Ho Memorial Hospital" was approved by the TFDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell therapy on February 13, 2020

" Kaohsiung Medical University Chung-Ho Memorial Hospital" was approved by the TFDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell therapy on February 13, 2020

" Kaohsiung Medical University Chung-Ho Memorial Hospital " is one of the Ever Supremes’ collaborating medical institutes.  It received approval by the Taiwan FDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell (DC) therapy.  Patients qualified to be admitted for relevant treatment includes indication such as breast cancer.